However, the drug remains one of the most effective ways of preventing serious illness and death Published 11/14/23, Sarah Braner The Messenger Viral rebound after taking Paxlovid may be more common than […]
Long Covid: Three years and no magic bullet
Published 2023 BBC, By Lucy Adams I have had long Covid for three years. Even though I have made huge progress I still suffer most days with chronic pain in […]
Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 – More infoView PDF Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19. […]
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders
Hironori Tsuchiya, Christos Rahiotis, Academic Editor and Nikolaos Gkantidis, Academic EditorDent J (Basel). 2023 Jun; 11(6): 140. Published online 2023 May 25. doi: 10.3390/dj11060140, PMCID: PMC10297082 PMID: 37366663 Abstract Since the worldwide spread of severe acute respiratory syndrome […]
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Theo Sanderson, Ryan Hisner, I’ah Donovan-Banfield, Hassan Hartman, Alessandra Løchen, Thomas P. Peacock & Christopher Ruis Nature (2023) Cite this article Abstract Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), acts by inducing […]
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19A Randomized Clinical Trial
Susanna Naggie, MD, MHS1,2; David R. Boulware, MD, MPH3; Christopher J. Lindsell, PhD4; et alThomas G. Stewart, PhD5; Alex J. Slandzicki, MD6; Stephen, C. Lim, MD Jonathan Cohen, MD8; David Kavtaradze, MD9, Arch Amon, MD10, et. al for the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. JAMA. 2023;329(11):888-897. doi:10.1001/jama.2023.1650 Question Does ivermectin, […]
Simvastatin in Critically Ill Patients with Covid-19
November 2, 2023, NEJM Abstract BACKGROUND The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS In an ongoing international, multifactorial, adaptive platform, randomized, […]
COVID-19 Therapeutics for Nonhospitalized Patients
Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint […]
Hydroxychloroquine Associated With Lower COVID-19 Mortality: French Study
NOV 03, 2023 – Authored by Zachary Stieber The Epoch Times People who received hydroxychloroquine were less likely to die than those who did not, according to a new study. […]
European Regulator Confirms Pfizer Did Not Highlight DNA Sequence In COVID-19 Vaccine
NOV 03, 2023 – Authored by Zachary Stieber The Epoch Times Pfizer did not highlight a DNA sequence in its COVID-19 vaccine, a European regulator has confirmed. “While the full DNA […]